Member Info for Laura2022

Herman

This is so oversold now and on all chart metrics (I have very basic knowledge!!) This seems .the bottom and there is the real possibility of bids too

Biostatistics service line

 

The Company was excited to announce its intention to develop a separate consulting service line focused on the delivery of biostatistics projects. Several complementary options are being pursued simultaneously to build out this new capability and a further update will be provided to the market towards the end of the current financial year. We anticipate that, if successful, this new service line could make a material contribution to the Company's revenues

Ant

I share that view too, plus the biostatistics division looks very exciting and Peter wording interesting

Interesting that out of all the TR1 holders and despite all the volume there has only been one change via holdings RNS

Suggests that people are keeping their cards close

Ýes, everything Peter has mentioned looks exciting and more ìmportantky they are one of only a few AIM companies actually growing and close to break even

Thankyou

It's hard to believe you can have c£900,000 revenues for full year (confirmed as being likely to be achieved twice) an a Conservative pipeline of £1,500,000 amd yet the entire business valued at only £1.5mln!

Good morning Trench

Is there an end date for the trials please ?

Hello Andrew

Ridiculous were only trading on 1.5 x expected earning !!

My purchases at 10.03p are looking healthy,long may it continue

With revenues expected to be £900,000- 1mln and pipeline increased to £1.5mln I have used some of the new ISA money to add more

Could see 200% r rise

Hello scdm

I purchased these on Friday and will look to add more ,REDX and SND the big movers this week ,both in similar situations but been taken down far too much

The full RNS is missing from LSE,there is a larger part about operational update below is the final part

 current reduction in production capacity is a consequence of the waste disposal issues that occurred at the mine in early 2024 and has also resulted in one of the Company's highwall miners being taken off site on a temporary basis.

 

Following the full draw down of the previously announced loan facility with Avani and the continued challenges the Company faces, as detailed above, the Company continues to manage its working capital position carefully and in this regard is assessing the options available to the Company at the present time.

 

New ISA year ahead now

It may be of interest

Elon musk company Neuralink rumoured to be bidding for SND whim worked with neuralink on the human brain chip

15 pence wouldn't be unreasonable as ROX have already put the floor at 10p

Other clients could be interested in SND ?

The Company is one of only a few companies capable of designing and supplying the higher-spec chips built on the most advanced semiconductor technologies, selling into a range of hyper growth end markets such as high-performance computing, automotive, artificial intelligence, VR/AR, video analytics, image processing, mobile networking and data centres.  Sondrel designs have enabled products by leading technology brands including Apple (iPhone), Sony (PlayStation), Meta's (Oculus), Samsung, Google and Sony smartphones, JVC (prosumer camcorders), Tesla and Mercedes-Benz cars

Hi newgrange

Are u still holding that other bio tech ?, with pipeline of over £1.5mln matching qlmost the entire market value it looks set..very good recent results too

Well done here

This was posted on Telegram

It is emerging that Neuralink could be one of the

interested parties circling  embattled British chip maker Sondrel. Recently it is believed  that Sondrel solved some of Neuralink problems with their recent human brain implant which other chip suppliers could not solve. Neuralink Corp. is an American neurotechnology company that is developing implantable brain–computer interfaces, based in  California and  founded by Elon Musk and a team of scientists and engineers.

Neuralink had recently livestreamed its first patient implanted with a chip playing online chess.

By way of context, Sondrel is one of only  a handful of firms capable of supplying the higher-spec chips required, others are in Asia but are  considered vulnerable to Chinese interference

 rumour that spread across the media this week, after the Daily Mail, quoting 'a source with knowledge of the matter', revealed that Sondrel played a key part in developing Tesla boss Elon Musk's brain–computer interface Neuralink.

According to sources, Musk called on Sondrel to lend its highly specialised knowledge of bespoke microchip designs to Neuralink, which was successfully implanted into a patient's brain for the first time last Sunday.

Thankyou scorcer

Something has to give soon ...